日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Novel 3D High-Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer.

一种新型 3D 高通量表型药物筛选流程，用于识别具有治疗卵巢癌潜力的药物

期刊:Advanced Healthcare Materials
影响因子:9.6
doi:10.1002/adhm.202404117
Karimnia Nazanin, Wilson Amy L, Doran Brittany R, Do Jennie, Matthews Amelia, Ho Gwo Y, Plebanski Magdalena, Jobling Thomas W, Stephens Andrew N, Bilandzic Maree
肿瘤
卵巢癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer

术前血清白细胞介素-6在诊断高级别浆液性卵巢癌中的应用

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-020-59009-z
Kampan, Nirmala Chandralega; Madondo, Mutsa Tatenda; Reynolds, John; Hallo, Julene; McNally, Orla M; Jobling, Thomas W; Stephens, Andrew N; Quinn, Michael A; Plebanski, Magdalena
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2020
文献求助 收藏

Surgical staging of para-aortic LN in patients with locally advanced cervix cancer and no evidence of metastases in preoperative PET/CT imaging

对局部晚期宫颈癌患者进行腹主动脉旁淋巴结的手术分期，这些患者的术前PET/CT影像检查未发现转移证据。

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2015.26.4.352
Lin, Ming Yin; Jobling, Thomas W; Narayan, Kailash
宫颈癌
肿瘤
肿瘤免疫
发表日期：2015
文献求助 收藏

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

一项针对晚期上皮性卵巢癌患者的自体树突状细胞治疗（针对黏蛋白1）的II期单臂研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1186/2051-1426-2-16
Mitchell, Paul Lr; Quinn, Michael A; Grant, Peter T; Allen, David G; Jobling, Thomas W; White, Shane C; Zhao, Anne; Karanikas, Vaios; Vaughan, Hilary; Pietersz, Geoffrey; McKenzie, Ian Fc; Gargosky, Sharron E; Loveland, Bruce E
肿瘤
肿瘤免疫
树突状细胞
卵巢癌
细胞生物学
树突状细胞
免疫/内分泌
发表日期：2014
文献求助 收藏